PCT/2001/1 - World Intellectual Property Organization

01/2001
46 PCT Gazette - Section I - Gazette du PCT 4 Jan/jan 2001
(22) 20 Jun/juin 2000 (20.06.2000)
(25) en (26) en
(30) 09/344,655 25 Jun/juin 1999 US
(25.06.1999)
(43) 4 Jan/jan 2001 (04.01.2001)
(54) METHODS AND COMPOSITIONS FOR
ENGINEERING OF ATTENUATED
VACCINES
PROCEDES ET COMPOSITIONS POUR
LA MISE AU POINT DE VACCINS AT-
TENUES
(71) MAXYGEN, INC. [US/US]; 515 Galweston
Drive, Redwood City, CA 94063 (US).
(for all designated States except / pour tous
les États désignés sauf US)
(72, 75) PUNNONEN, Juha [FI/US]; 4290
Wilkie Way, #P, Palo Alto, CA 94306 (US).
HOWARD, Russel [AU/US]; 12700 Viscaino
Road, Los Altos Hills, CA 94022 (US).
STEMMER, Willem, P., C. [NL/US]; 108
Kathy Court, Los Gatos, CA 95032 (US).
DELCARDAYRE, Stephen [US/US]; 2049
Monroe Avenue, Belmont, CA 94002 (US).
APT, Doris [DE/US]; 917 Tamarack Lane,
#3, Sunnyvale, CA 94068 (US).
(74) SMITH, Timothy, L. et al. / etc.; Townsend
and Townsend and Crew LLP, Two Embarcadero
Center, 8th Floor, San Francisco, CA
94111-3834 (US).
(81) AE AG AL AM AT AU AZ BA BB BG BR
BY BZ CA CH CN CR CU CZ DE DK DM
DZ EE ES FI GB GD GE GH GM HR HU
ID IL IN IS JP KE KG KP KR KZ LC LK
LR LS LT LU LV MA MD MG MK MN MW
MX MZ NO NZ PL PT RO RU SD SE SG SI
SK SL TJ TM TR TT TZ UA UG US UZ VN
YU ZA ZW.
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ
UG ZW); EA (AM AZ BY KG KZ MD RU
TJ TM); EP (AT BE CH CY DE DK ES FI FR
GB GR IE IT LU MC NL PT SE); OA (BF BJ
CF CG CI CM GA GN GW ML MR NE SN
TD TG).
(51) 7 A61K 39/00, 39/40, 39/395, G01N 33/543,
33/563, 33/566, C07K 16/00, C07H 21/04
(11) WO 01/00235
(21) PCT/US00/17927
(13) A1
(22) 29 Jun/juin 2000 (29.06.2000)
(25) en (26) en
(30) 09/342,426 29 Jun/juin 1999
(29.06.1999)
US
(43) 4 Jan/jan 2001 (04.01.2001)
(54) PRION PROTEIN BINDING PROTEINS
AND USES THEREOF
PROTEINES DE LIAISON A LA PRO-
TEINE PRION, ET LEURS UTILISA-
TIONS
(63) US 09/342,426 (CIP)
29 Jun/juin 1999 (29.06.1999)
(71) McGILL UNIVERSITY [CA/CA]; 3550
University Street, Montreal, Quebec H3A
2A7 (CA). CAPRION PHARMACEUTI-
CALS, INC. [CA/CA]; Suite 201, 5375 Pare
Street, Montreal, Quebec H4P 1P7 (CA).
(for all designated States except / pour tous
les États désignés sauf US)
(72, 75) CASHMAN, Neil, R. [US/CA]; 1
Denewood Circle, Toronto, Ontario M3B
1M5 (CA). DODELET, Vincent [CA/CA];
4826 Clark Street, Montreal, Quebec H2T
2T5 (CA). PARAMITHIOTIS, Eustache
[CA/CA]; 208 Alfred Laliberte, Boucherville,
Quebec J4B 1B9 (CA).
(74) ELBING, Karen, L.; Clark & Elbing LLP,
176 Federal Street, Boston, MA 02110-2214
(US).
(81) AE AG AL AM AT AU AZ BA BB BG BR
BY BZ CA CH CN CR CU CZ DE DK DM
DZ EE ES FI GB GD GE GH GM HR HU
ID IL IN IS JP KE KG KP KR KZ LC LK
LR LS LT LU LV MA MD MG MK MN MW
MX NO NZ PL PT RO RU SD SE SG SI SK
SL TJ TM TR TT TZ UA UG US UZ VN YU
ZA ZW.
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ
UG ZW); EA (AM AZ BY KG KZ MD RU
TJ TM); EP (AT BE CH CY DE DK ES FI FR
GB GR IE IT LU MC NL PT SE); OA (BF BJ
CF CG CI CM GA GN GW ML MR NE SN
TD TG).
Published / Publiée :(c)
(51) 7 A61K 39/125
(11) WO 01/00236 (13) A1
(21) PCT/FI00/00220
(22) 17 Mar/mar 2000 (17.03.2000)
(25) en (26) en
(30) 60/140,872 24 Jun/juin 1999 US
(24.06.1999)
(43) 4 Jan/jan 2001 (04.01.2001)
(54) PREVENTION OF TYPE 1 DIA-
BETES AND OTHER NON-POLIO
ENTEROVIRUS DISEASES
PREVENTION DU DIABETE INSU-
LINO-DEENDANT ET AUTRES MA-
LADIES ENTEROVIRALES AUTRE
QUE LA POLIOMYELITE
(71, 72) HYÖTY, Heikki [FI/FI]; Minna Canthin
Katu 3 B, Fin-33230 Tampere (FI). KNIP,
Mikael [FI/FI]; Palomäentie 11 A, Fin-33230
Tampere (FI).
(74) KOLSTER OY AB; Iso Roobertinkatu 23,
P.O. Box 148, Fin-00121 Helsinki (FI).
(81) AE AG AL AM AT AT (Utility model / modèle
d’utilité) AUAZBABBBGBRBYCA
CH CN CR CU CZ CZ (Utility model / modèle
d’utilité) DE DE (Utility model / modèle
d’utilité) DK DK (Utility model / modèle
d’utilité) DM DZ EE EE (Utility model / modèle
d’utilité) ES FI FI (Utility model / modèle
d’utilité) GBGDGEGHGMHRHUIDIL
IN IS JP KE KG KP KR KR (Utility model
/ modèle d’utilité) KZLCLKLRLSLTLU
LV MA MD MG MK MN MW MX NO NZ
PL PT RO RU SD SE SG SI SK SK (Utility
model / modèle d’utilité) SLTJTMTRTT
TZ UA UG US UZ VN YU ZA ZW.
(84) AP (GH GM KE LS MW SD SL SZ TZ UG
ZW); EA (AM AZ BY KG KZ MD RU TJ
TM); EP (AT BE CH CY DE DK ES FI FR
GB GR IE IT LU MC NL PT SE); OA (BF
BJ CF CG CI CM GA GN GW ML MR NE
SN TD TG).
(51) 7 A61K 39/385, C12P 21/00, C07K 16/00,
17/00, G01N 33/48
(11) WO 01/00237 (13) A1
(21) PCT/US00/17609
(22) 27 Jun/juin 2000 (27.06.2000)
(25) en (26) en
(30) 60/141,699 30 Jun/juin 1999
(30.06.1999)
US
(43) 4 Jan/jan 2001 (04.01.2001)
(54) SYNTHETIC PEPTIDE IMMUNOGENS
AND ANTIBODIES THERETO
IMMUNOGENES PEPTIDIQUES DE
SYNTHESE ET ANTICORPS CONTRE
CES IMMUNOGENES
(71) SIGMA-ALDRICH CO. [US/US]; 509
West Monroe Street, Highland, IL 62249
(US).
(72) GOLDFORD, Marc; 704 Bitterfield Drive,
Ballwin, MO 63011 (US). TRISCOTT,
Mark, X.; 461 Governors Court, Ballwin,
MO 63021 (US).
(74) HEJLEK, Edward, J. et al. / etc.; Senniger,
Powers, Leavitt & Roedel, One Metropolitan
Square, 16th Floor, St.
(US).
(81) AU CA JP.
Louis, MO 63102
(84) EP (AT BE CH CY DE DK ES FI FR GB GR
IE IT LU MC NL PT SE).
(51) 7 A61K 39/395, A61P 35/00
(11) WO 01/00238 (13) A1
(21) PCT/US00/17423
(22) 23 Jun/juin 2000 (23.06.2000)
(25) en (26) en
(30) 60/141,315 25 Jun/juin 1999 US
(25.06.1999)
(43) 4 Jan/jan 2001 (04.01.2001)
(54) TREATING PROSTATE CANCER WITH
ANTI-ErbB2 ANTIBODIES
TRAITEMENT DU CANCER DE LA
PROSTATE A L’AIDE DES ANTICORPS
ANTI-ERBB2
(71) GENENTECH, INC. [US/US]; 1 DNA
Way, South San Francisco, CA 94080-4990
(US). SLOAN-KETTERING INSTITUTE
FOR CANCER RESEARCH [US/US]; 460
E. 63rd Street, New York, NY 10021 (US).
(72) AGUS, David, B.; 522 North Crescent Drive,
Beverly Hills, CA 90210 (US). SCHER,
Howard, I.; 264 Highwood Avenue, Tenafly,
NJ 07670 (US). SLIWKOWSKI, Mark, X.;
42 Oak Creek Lane, San Carlos, CA (US).
(74) LEE, Wendy, M. et al. / etc.; Genentech,
Inc., 1 DNA Way, South San Francisco, CA
94080-4990 (US).
(81) AE AG AL AM AT AU AZ BA BB BG BR
BY BZ CA CH CN CR CU CZ DE DK DM
DZ EE ES FI GB GD GE GH GM HR HU
ID IL IN IS JP KE KG KP KR KZ LC LK
LR LS LT LU LV MA MD MG MK MN MW
MX MZ NO NZ PL PT RO RU SD SE SG SI
SK SL TJ TM TR TT TZ UA UG UZ VN YU
ZA ZW.
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ
UG ZW); EA (AM AZ BY KG KZ MD RU
TJ TM); EP (AT BE CH CY DE DK ES FI FR
GB GR IE IT LU MC NL PT SE); OA (BF BJ
CF CG CI CM GA GN GW ML MR NE SN
TD TG).
Published / Publiée :(c)